Showing results (1391-1400 of 5,921) with videos related to

Sort By:
Pageof 593
ACS Applied Materials & Interfaces|August 10, 2019
Tumor-Specific Expansion of Oxidative Stress by Glutathione Depletion and Use of a Fenton Nanoagent for Enhanced Chemodynamic TherapyQiufang Chen, Jun Zhou, Zhe Chen, et al.
Cancer Biology & Therapy|November 9, 2018
Knockdown of linc00152 inhibits the progression of gastric cancer by regulating microRNA-193b-3p/ETS1 axisHaifang Wang, Wenxiang Chen, Peng Yang, et al.
Neurochemical Research|February 5, 2017
Reversal of TRESK Downregulation Alleviates Neuropathic Pain by Inhibiting Activation of Gliocytes in the Spinal CordJun Zhou, Hongtao Chen, Chengxiang Yang, et al.
Algorithms for Molecular Biology : AMB|October 1, 2016
Analysis of gene copy number changes in tumor phylogeneticsJun Zhou, Yu Lin, Vaibhav Rajan, et al.
Optics Express|March 17, 2019
High-efficiency broadband vortex beam generator based on transmissive metasurfaceShiwei Tang, Xike Li, Weikang Pan, et al.
Biosensors|November 23, 2018
One-Pot Synthesis of Multi-Branch Gold Nanoparticles and Investigation of Their SERS PerformanceWeifeng Lv, Chenjie Gu, Shuwen Zeng, et al.
Oncology Letters|October 19, 2018
Never-in-mitosis A-related kinase 8, a novel target of von-Hippel-Lindau tumor suppressor protein, promotes gastric cancer cell proliferationXiao-Fei Ding, Jie Chen, Jun Zhou, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|January 10, 2008
[Comparison of cyclophosphamide and cyclosporine in the treatment of steroid-resistant idiopathic nephrotic syndrome in children]Jia Rao, Hong Xu, Qi Cao, et al.
Nutrition Research (New York, N.Y.)|November 10, 2021
Mechanistic basis and preliminary practice of butyric acid and butyrate sodium to mitigate gut inflammatory diseases: a comprehensive reviewMingbao Zhang, Yanan Wang, Xianqi Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2012
The activation of MAPK in melanoma cells resistant to BRAF inhibition promotes PD-L1 expression that is reversible by MEK and PI3K inhibitionXiaofeng Jiang, Jun Zhou, Anita Giobbie-Hurder, et al.
Pageof 593